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During recent years, right ventricular (RV) structure and function have been found to be an important determinant of outcome in different
cardiovascular and also pulmonary diseases. Currently, echocardiography and cardiac magnetic resonance (CMR) imaging are the two
imaging modalities most commonly used to visualize the RV. Most structural abnormalities of the RV can be reliably described by echocardi-
ography but due its complex geometrical shape, echocardiographic assessment of RV function is more challenging. Newer promising echocar-
diographic techniques are emerging but lack of validation and limited normal reference data influence their routine clinical application. Cardiac
magnetic resonance is generally considered the clinical reference technique due to its unlimited imaging planes, superior image resolution, and
three-dimensional volumetric rendering. The accuracy and reliability of CMR measurements make it the ideal tool for serial examinations of RV
function. Multidetector computed tomography (MDCT) plays an important role in the diagnosis of pulmonary emboli but can also be used for
assessing RV ischaemic disease or as an alternative for CMR if contra-indicated. Radionuclide techniques have become more obsolete in the
current era. The different imaging modalities should be considered complimentary and each plays a role for different indications.
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Introduction
The right ventricle (RV) has for a long time been the neglected side
of the heart, but its role in different cardiovascular diseases has
been increasingly recognized. This is obvious for structural con-
genital heart defects (CHD) involving the RV such as pulmonary
valve stenosis, tetralogy of Fallot (TOF), and Ebstein malforma-
tion.1 Beyond this, RV function has been shown to be one of the
most important outcome determinants in patients with pulmonary
arterial hypertension (PAH).2,3 Also in patients with cardiomyop-
athy and ischaemic heart disease, RV dysfunction has been
shown to be a strong predictor of adverse events, independent
from left ventricular (LV) function and the presence of ischae-
mia.4 –6 Different imaging modalities can be used for imaging the
RV. Due to technological advances, the role and clinical use of
these techniques is evolving. In different conditions, each technique
provides complementary information and this influences its use in
clinical practice. Currently, echocardiography and cardiac magnetic
resonance (CMR) imaging are the two most commonly used
imaging techniques for structural and functional evaluation of the
RV.7 Other imaging modalities such as multidetector-computed
tomography (MDCT) and radionuclide techniques are valuable
alternatives in selected patients.
Right ventricular structure and
function
Correct identification of the morphologic RV is the first important
step for RV assessment, independently from the imaging modality
used. The segmental approach to cardiac anatomy helps define
the cardiac structures and segments based on constant anatomical
features.8 –11 The gross anatomy of the RV differs from the LV as it
has a more complex geometrical shape being ‘wrapped around’ the
LV. This complex geometry precludes imaging the inflow and
outflow tract in a single two-dimensional plane. Compared with
the LV, the RV myocardium is significantly more trabeculated,
and the RV wall much thinner with a normal compacted wall thick-
ness of 3–5 mm in the adult population.
The structural organization of the myocardial cells has a charac-
teristic complex three-dimensional myofiber arrangement.12,13 The
LV wall has a three-layered structure with the epicardial cells
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oriented obliquely, the mid-myocardial cells more circumferential-
ly, and the endocardial cells again obliquely. The well-developed
midwall circumferential layer is responsible for the predominance
of circumferential shortening and radial thickening in the LV. The
RV epicardial fibres are oriented obliquely and contiguous with
epicardial LV fibres, the midwall circumferential layer is poorly
developed and the endocardial fibres are oriented longitudinally.
This fibre structure explains why RV ejection is determined by lon-
gitudinal shortening rather than by circumferential deformation.
The normal RV contraction results in a peristaltic contraction
going from the inflow to the outflow part of the RV.14 In case of
RV hypertrophy, the hypertrophied fibres seem to be oriented
more circumferentially and circumferential and radial shortening
contribute more to RV ejection.15,16
The RV is also functionally different from the LV.17–19 Right ven-
tricular pressure–volume loops are more triangular compared
with the rectangular LV loops and have very short or absent isovo-
lumetric contraction and relaxation periods.18 The RV responds
differently to acute and chronic stressors as well as to pharmaco-
logical agents. The RV is more sensitive to both acute and chronic
pressure loading and is at risk for acute and chronic RV failure.19
Recent data have suggested that in both ventricles, different mo-
lecular pathways are involved in the adaptive myocardial response
to changes in loading conditions.20–22 This could be related to the
different embryologic origin of RV and LV myocardial cells23,24 and
has potential implications for targeted pharmacological treatment
of RV failure.
Interventricular interaction is another important aspect of RV
disease: RV hypertrophy and/or dilatation affect LV function.25 –28
The increased transseptal gradient associated with RV hyperten-
sion causes bowing of the interventricular septum towards the
LV. In RV dilatation, this occurs during diastole influencing LV
filling, and in the case of elevated RV systolic pressure, this can
affect LV systolic function and mechanics. Thus, RV abnormalities
may indirectly affect LV output and overall cardiac performance.
Imaging modalities
Echocardiography
Right ventricular morphology can generally be adequately
described by transthoracic echocardiography in most patients.
Only when transthoracic imaging windows are poor and RV
disease is suspected, additional imaging may be required. Depend-
ing on patient age and clinical problem, transoesophageal echocar-
diography, CMR, or MDCT can be used.
Assessment of RV size and function should be part of every
echocardiographic examination at the time of first diagnosis and
during serial follow up, particularly in patients with chronic condi-
tions, such as PAH and cardiomyopathy. Guidelines for the echo-
cardiographic evaluation of the RV have been published for the
adult29 and paediatric population.30 Both guidelines stress the im-
portance of combining different 2D echocardiographic views for
obtaining full coverage of the different RV segments. Different
apical views as well as subcostal and parasternal long-axis and
short-axis views should be acquired (Figure 1). Echocardiographic
evaluation should also include 2D measurements of right atrial
dimensions and RV wall thickness. The most commonly used
normal values for the adult population reported in the echocardio-
graphic guidelines as a summary of several studies are shown in
Table 1. These proposed normal data have some limitations: the re-
producibility of different measurements needs to be tested and the
normal data will have to be stratified for age ranges, body size, and
gender. Assessment of RV volumes using 2D echocardiography is
more challenging. Two-dimensional RV measurements as well as
different geometrical formula proposed for volume calculation
Figure 1 Measurement of right ventricular (RV) dimensions using echocardiography. Two-dimensional measurements should be made in dif-
ferent parts of the RV. (A) From the apical four-chamber view, the inflow part of the RV is measured as the maximal short-axis dimension in the
basal one-third of the RV (RV1). The midcavity dimension is measured in the middle third of the RV at the level of the papillary muscles (RV2).
This represents the trabecular part of the RV. The longitudinal dimension is measured from the middle of the tricuspid valve to the RV apex
(RV3). (B) From the parasternal long-axis view, the proximal part of the right ventricular outflow tract is measured.
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show poor agreement with three-dimensional (3D) volumes calcu-
lated by CMR.31,32 Recently, 3D echocardiography has emerged as
a promising technique for the assessment of RV volumes.33 Differ-
ent methods have been proposed for the analysis of 3D volumetric
data sets; the most commonly used being the Beutel technique.34–38
This method has been proven to be reliable and accurate in different
conditions, including CHD and PAH. The challenge of acquiring a
good quality full volumetric 3D data set, including the RV anterior
wall and the RV apical lateral segments, in patients with poor
imaging windows and/or dilated RV is the main limitation of the
method. Moreover, accuracy tends to decrease with increasing RV
dilatation, limiting its application in the more dilated ventricles.34,39
Three-dimensional echocardiography can also be useful for
imaging the tricuspid valve, as all three leaflets and commissures
can be visualized in a single 3D image. The mechanisms of tricuspid
regurgitation can be better understood, which facilitate guiding sur-
gical repair.40–42
Due to the limitations discussed above, echocardiographic as-
sessment of RV function remains challenging in clinical practice
and often is limited to subjective qualitative assessment. Recent
guidelines recommend performing quantitative measurements of
RV function29,30 by using at least one of the following echocardio-
graphic parameters as surrogate of volumetric assessment of RV
function: percent fractional area change (FAC), tricuspid annular
plane systolic excursion (TAPSE), or RV index of myocardial per-
formance (RIMP) (Table 2). The observation that the combined
use of three different parameters is being proposed probably indi-
cates that no single measurement has been validated for clinical use
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Two-dimensional measurements of the right ventricular cavity
Normal value Limitation
2D RV measurements
RV 1 (RV basal diameter) ,4.2 cm Influenced by probe rotation
Requires RV-focused view
RV 2 (midcavity diameter) ,3.5 cm Level of measurement not clearly defined
(level LV papillary muscles)
Normal value?
RV 3 (base-apex RV length) ,8.6 cm Influenced by probe rotation
Definition of RV apex?
RV end-diastolic area ,28 cm2 Influenced by probe rotation
Definition of trabeculations can be difficult
RVOT parasternal short axis just proximal to pulmonary valve 2.7 cm Often difficult endocardial definition
Limited normative data
RVOT parasternal long axis 3.3 cm Anterior wall definition can be difficult
Limited normative data
2D right atrial dimensions
RA major dimension (apical 4C) ,5.3 cm Influenced by imaging plane
Relatively few normative data
RA minor dimension ,4.4 cm Imaging plane will affect measurement
RA end-systolic area ,20 cm2 Few normative data
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Right ventricular functional measurements
Measurement Normal value Limitation
%FAC .35% Endocardial border detection can be difficult especially in systole
Load-dependent
No imaging of the outflow tract
TAPSE .16 mm Influenced by direction of motion (alignment)
Influenced by loading and tricuspid regurgitation
No imaging of the outflow tract
Peak systolic tissue Doppler velocity
tricuspid annulus
.10 cm/s Influenced by alignment with the motion
Influenced by loading conditions
Only one single segment used for global function
Peak systolic longitudinal strain of the
RV lateral wall
No good reference value Needs further validation
Normative data are needed
FAC, fractional area change; TAPSE, tricuspid annular plane excursion.
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in different conditions and that their impact on management and
outcome remains uncertain.
Fractional area change (Figure 2) has been shown to correlate
with RV EF calculated by CMR and to be an independent predictor
for outcome after myocardial infarction.43 However, image quality
and visualization of the endocardial borders are often limited espe-
cially in the RV lateral wall and RV apex. Tricuspid annular plane
systolic excursion (Figure 3) is easy to measure and represents lon-
gitudinal shortening of the RV lateral wall, but normal values for
different age groups and its validation are limited.29 In addition,
the presence of tricuspid regurgitation may influence the values
obtained. Right ventricular index of myocardial performance is a
Doppler method combining measurement of isovolumic contrac-
tion and relaxation times.44 Right ventricular index of myocardial
performance is load dependent and due to the short RV isovolu-
mic time intervals, its use remains controversial.45
Emerging echocardiographic techniques like tissue Doppler
(TDI) and strain imaging have been applied to the assessment of
RV function. Peak tissue Doppler systolic velocity in the tricuspid
annulus is a measurement of RV longitudinal function (Figure 4).
Figure 2 Measurement of fractional area change (FAC). Right ventricular end-diastolic and end-systolic area is measured from an apical four-
chamber view. FAC is calculated as (end-diastolic area-end-systolic area)/end-diastolic area. In the example shown FAC is 50% (normal value
.35%).
Figure 3 Tricuspid annular planar systolic excursion (TAPSE). From the apical four-chamber view, an M-mode is put through the tricuspid
annulus with as good alignment as possible with longitudinal motion of the annulus. The systolic displacement of the tricuspid annulus is mea-
sured. To optimize timing, we use tissue colour M-mode which allows to well define end-diastole and end-systole on the tracings. TAPSE should
be .1.6 cm.
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This technique is easy and reproducible but has the limitations of
being angle-dependent, load-dependent, and influenced by the
global cardiac translation and tricuspid regurgitation. In the young
adult, a normal cut-off value of ≥10 cm/s has been proposed;
however, normal data for all different age ranges and gender are
lacking.29
The introduction of speckle-tracking echocardiography made
the measurement of strain and strain rate easier. Although devel-
oped for the LV, speckle tracking has been applied to the RV.7,46
Peak longitudinal strain and strain rate measurement are independ-
ent from global cardiac motion and allow quantifying regional myo-
cardial deformation in the different RV segments. Right ventricular
strain has been shown to be reduced in patients with PAH,25,47,48 a
systemic RV,49,50 and after TOF repair51,52 (Figure 5). Although very
promising, myocardial deformation imaging has significant limita-
tions. Strain values are influenced by loading conditions, as it has
been demonstrated in patients with PAH, in whom RV longitudinal
strain was related to pulmonary arterial systolic pressures.25 Add-
itionally, strain values are influenced by RV size and stroke volume.
Feasibility is not always given in the thin RV wall; normal values for
different age ranges, body size, and gender still have not been
established yet; standardization among different software solutions
is still being investigated. Therefore, TDI and speckle tracking are
not ready yet for routine clinical use.53
Figure 4 Pulsed tissue Doppler of the tricuspid annulus. This a pulsed Doppler tracing obtained in the tricuspid annulus from the apical four-
chamber view. A systolic peak velocity (S′), early diastolic velocity (E′), and atrial contraction velocity (A′) can be measured. Notice on this trace
the near absence of isovolumetric periods in this normal right ventricle. After systole, the early diastolic wave starts, after diastolic, during the
isovolumetric period there is a short isovolumetric peak corresponding to changes in the myocardium during the isovolumetric period.
Figure 5 Longitudinal strain measurement in the right ventricular (RV) free wall. From the apical four-chamber view, strain curves are
obtained using speckle tracking echocardiography. On the left panel, strain in the RV free wall was measured in a postoperative tetralogy of
Fallot patient. This patient underwent pulmonary valve replacement and the right-hand panel reflects strain measurements 6 months after
the surgery. A reduction in strain may result from changes in RV stroke volume, RV preload, and RV geometry.
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Cardiovascular magnetic resonance
Cardiovascular magnetic resonance is the second-line modality
after echocardiography for comprehensive RV evaluation. Cardio-
vascular magnetic resonance is currently considered the reference
standard for functional RV studies as it allows visualizing anatomy,
quantifying function, and calculating flows.
Anatomical assessment is usually performed with T1-weighted
black-blood turbo spin-echo sequence or with the steady-state
free precession (SSFP) sequence. Standard axial images allow seg-
mental analysis of cardiac anatomy and visualization of the pulmon-
ary arteries, pulmonary veins, aorta, and systemic veins. Detailed
description of the intra- and extracardiac anatomy can be achieved
by 3D rendering techniques, including contrast-enhanced MR angi-
ography and 3D SSFP. This is important for detailed description of
complex cardiac anatomy and for preoperative planning.54,55
Cardiovascular magnetic resonance also provides advanced
imaging of the RV myocardium inclusive tissue characterization.
Different T1- and T2-weighted sequences combined with
late-enhancement imaging after gadolinium administration can be
used for tissue characterization. Tissue characterization is used
for assessment and differentiation of different cardiomyopathies
affecting the RV, including arrhythmogenic RV cardiomyopathyopa-
thy (ARVC), metabolic storage diseases, and cardiac tumours.56–59
Late enhancement imaging shows intramyocardial fibrosis, inflam-
mation, scars, and fat accumulation (Figure 6). In CHD, the pres-
ence of myocardial scars in the RV is supposed to be a risk
factor for adverse events during follow-up.60,61 Interpretation of
the images can be challenging due to the thin RV wall and the sur-
rounding epicardial fat and pericardium. The prognostic signifi-
cance of myocardial late-enhancement in various diseases needs
further investigation.
Cardiovascular magnetic resonance is considered the clinical ref-
erence technique for accurate assessment of global RV function.
Short-axis or axial SSFP images and the summation disc method
are used for calculation of RV volumes and ejection fraction (EF)
without any geometrical assumption (Figure 7). Appropriate
spatial and temporal resolution of the images is important for ac-
curacy of the results and can be achieved by adjusting acquisition
parameters to the patient’s size and heart rate.62 Normal age-
and gender-specific values for RV volumes and function have
been published for the adult and the paediatric population.63,64
Provided adequate standardization, CMR RV measurements
show high reproducibility with an interobserver variability ,7%
for the end-diastolic volume, ,14% for the end-systolic volume,
,7% for EF, and ,20% for RV mass.63– 67 Right ventricular seg-
mentation is more challenging than LV segmentation and variability
of the data can be influenced by sternal wires obscuring the RV an-
terior wall, correct identification of the level of tricuspid and pul-
monary valve, the thin RV wall, the complex trabeculated RV
cavity, and the partial volume effect in the RV apex.64 Axial acqui-
sition of the images has been reported to improve accuracy of the
measurements,68 but normal data are only available for
children.65,68
Regional RV function can be evaluated qualitatively at rest and
during pharmacological stress on SSFP short-axis cine loops.69 Re-
gional dysfunction can be assessed quantitatively by using myocar-
dial tagging or strain encoding CMR; both techniques have been
shown to be feasible in the RV correlate well with echocardio-
graphic evaluation.70,71 However, their application in the RV is
technically demanding, due to the thin wall, and extensive post
processing, limiting their clinical application.72
Velocity-encoded phase contrast imaging is another important
CMR tool for RV evaluation. Phase contrast imaging enable quan-
tification of RV stroke volume, pulmonary and/or tricuspid valve
regurgitation, intracardiac shunts as well as of differential lung per-
fusion.73– 75
Multidetector computed tomography
Multidetector computed tomography is not a routinely used tech-
nique for RV assessment, due to the significant radiation exposure
and the use of iodinated contrast medium.76 Multidetector com-
puted tomography is usually performed when concomitant thor-
acic or pulmonary disorders, such as pulmonary embolism (PE),
are suspected. Multidetector computed tomography is a valuable
alternative to CMR in patients with pacemaker, CMR incompatible
prosthetic material and claustrophobia. Recent improvements in
temporal and spatial resolution affected cardiac visualization.76
The use of MDCT for the RV has mainly been validated for the de-
tection of PE and for work up of pulmonary hypertension.77 Multi-
detector computed tomography is increasingly used for detecting
coronary artery disease as its accuracy has been demonstrated
for non-invasive visualization of both coronary arteries.78,79 Re-
cently, radiation dose could be importantly reduced also in com-
parison to diagnostic coronary angiography.80
Structural evaluation of the RV by MDCT includes measurement
of RV size and volumes, as well as RV free myocardial wall thick-
ness (RV hypertrophy). Septal bowing into the LV indicates RV
volume (diastolic bowing) or pressure overload (systolic bowing).
Figure 6 Late gadolinium enhancement in the right ventricular
free wall. Late enhancement indicating fibrosis of the right ven-
tricular and left ventricular myocardium (arrows) in a patient
with Naxos disease, a disease associated with right ventricular
arrhythmogenic ventricular dysplasia.
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The diameters of the systemic veins and pulmonary arteries are in-
direct measures of elevated preload and afterload, respectively.81
Normal values for RV structures measured by MDCT have been
recently published.82 ECG-gating during image acquisition is
needed for functional assessment and for CT angiography of the
coronary arteries. Therefore, beta-blockers are usually adminis-
tered in patients with heart rate .75 per min for optimizing
image acquisition.76 Compared with CMR, MDCT has lower tem-
poral resolution and tends to overestimate end-systolic and end-
diastolic volumes.83
Radionuclide techniques
Radionuclide techniques have historically been the first modalities
used for assessing RV function.84 They have largely been replaced
by CMR and echocardiography. Nonetheless, radionuclide modal-
ities still play a role in assessment of RV myocardial ischaemia and
in patients in whom CMR is contraindicated.85 Among different
techniques tested, gated blood-pool single photon emission com-
puted tomography (SPECT) is the currently recommended
nuclear modality for quantifying RV function, as its 3D nature over-
comes the common limitations of other nuclear techniques.84,86
Gated SPECT is able to provide RV volumetric and functional
data,87 but further studies for validation of automatic measurement
algorithms are still pending.
Radionuclide techniques are of additional particular interest for
assessing myocardial metabolism and perfusion. The use of posi-
tron emission tomography (PET) or SPECT for RV evaluation is
in general limited by the lower overall counts attributable to the
RV compared with the LV causing inconsistent RV visualization.84
In the pathologic RV, hypertrophy leads to an increased RV
tracer uptake and results in improved RV visualization. In PAH,
changes in RV myocardial metabolism and perfusion are thought
to be a precursor of deterioration of systolic function, RV failure,
and/or clinical symptoms, and may be used for guiding therapeutic
decision making.85 Experimental studies using SPECT have shown
that acute or chronic RV pressure overload leads to a myocardial
metabolic shift from fatty acid to glucose.88 Positron emission tom-
ography may be superior to SPECT for visualization of the RV, due
to its superior spatial resolution and attenuation correction. More
recently, 18F-fluorodeoxyglucose PET has been utilized to assess
response to epoprostenol therapy in PAH patients.89
Finally, new hybrid SPECT/CT and PET/CT systems are being
used in the LV for assessing myocardial perfusion, metabolism,
function, and anatomy (coronary arteries) in one single examin-
ation. Their feasibility in the RV still needs to be demonstrated.90
Clinical application of non-invasive
imaging in conditions affecting the
right ventricle
Pulmonary arterial hypertension
Echocardiography plays an important role in the clinical detection
of PAH and in the diagnostic work-up of some of its causes like
Figure 7 Measurement of right ventricular (RV) volume and function by SSFP. (A) A stack of 10–12 adjacent slices are acquired on a vertical
long-axis view showing both atria and both ventricles. (B) Endocardial contours (yellow line for RV, red line for LV, green line for LV epicardium)
of each ventricle are traced in the end-systolic and end-diastolic phase during postprocessing. (C) Data analysis is performed with the summa-
tion disc method, which provides the real shape of the right ventricle (yellow).
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left-sided heart disease or CHD. In patients with PAH at the time
of first diagnostic work up, MDCT is an established modality for
exclusion of pulmonary tissue disease, vascular disease, and
PE.77,91 Cardiovascular magnetic resonance adds information
about flow velocities and profiles in the pulmonary arteries and
veins.
Right ventricular function has been shown to be an important
predictor of survival in patients with PAH.92,93 The increased after-
load caused by the increased pulmonary vascular resistance causes
RV hypertrophy and remodelling. With the progression of the
disease, the hypertrophic response becomes inadequate and can
be associated with pathological changes, such as progressive RV
myocardial fibrosis and dysfunction. Different echocardiographic
measurements have been shown to have prognostic value in
patients with PAH and are summarized in Table 3. Right atrial
and RV size, %FAC, and TAPSE26,94 are good parameters for mon-
itoring the therapeutic effect of pulmonary vasodilator treatment.
Three-dimensional echocardiography has been proposed for mon-
itoring progressive RV dilatation as a marker for disease progres-
sion.95 The effects of vasodilator therapy could be monitored by
CMR, as RV volume, function, and mass can be measured more re-
liably and RV output can be calculated with two different techni-
ques (volumetry and blood flow). Cardiac magnetic resonance
has a higher sensitivity for detecting serial changes.96 The limited
accessibility and cost are probably the main reason why it is not
routinely used for follow-up in most centres. Recent CMR
studies demonstrated a high incidence of fibrotic areas in the RV
myocardium in PAH patients. This finding suggests that a patho-
logical fibrotic response may contribute to progressive RV failure
in these patients.97 Recent echocardiographic studies suggested
that RV apex function may be affected more significantly than
other RV segments.98 All these data show how multimodality
imaging of the RV plays an important role in the diagnosis and man-
agement of patients with PAH.
Multidetector computed tomography has become the most im-
portant imaging test in the diagnosis of acute PE.91 Due to its very
high negative predictive value (around 95%), MDCT can be used
practically as a stand-alone test for the exclusion of acute PE.99
Whereas scintigraphy is still used as the main screening tool for
evaluation of chronic thromboembolic pulmonary hypertension,
in an acute setting and in most centres MDCT has replaced venti-
lation–perfusion scanning because of the high number of inconclu-
sive results of the latest.100 Echocardiography has a low sensitivity
in diagnosing PE (60–70%) and is mainly used for risk stratifica-
tion.101 The echocardiographic criteria suspicious for PE include
RV dilatation, hypokinesis, and signs of pulmonary hypertension
such as increased tricuspid regurgitation velocity.91 Patients with
RV dysfunction related to PE have been shown to be at higher
risk for early mortality.102
Ischaemic right ventricular disease and
right ventricular failure
Although isolated RV myocardial infarction is extremely rare, RV
ischaemia complicates up to 50% of inferior myocardial infarc-
tions.103 In acute RV ischaemia, RV free wall hypokinesia or akin-
esia detected by echocardiography is a qualitative and sensitive
parameter for RV dysfunction,104 and in combination with RV
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Table 3 Prognostic value of echocardiographic measurements in pulmonary hypertension
Imaging parameter Predictive value Limitation
Right atrial size indexed for height136 Increase in 5 cm2/m increases the hazard for death by
1.54 (95% confidence interval: 1.13–2.10)
Variability in imaging of the RA
RV diameter137 36.5 mm - death rate increase from 6.6/100 person
years (diameter ,36.5 mm) to 15.9/100 person
years (diameter .36.5 mm)
Needs further validation
Myocardial performance index138 Normal 0.28+0.04 No cut-off value
Predictor of adverse outcome (increase by 0.1 unit
increases the hazard ratio 1.3; 95% confidence
interval :1.09–1.56)
Influenced by loading conditions
TAPSE3 Cut-off value 1.8 cm Angle-dependent
For every 1 mm decrease in TAPSE, the unadjusted
risk of death increased by 17% (hazard ratio, 1.17;
95% confidence interval 1.05–1.30)
Influenced by overall cardiac motion
Pulmonary vascular capacitance
(stroke volume/pulse pressure)139,140
Systolic PA pressure from TR-jet; diastolic pressure
from PR-jet and stroke volume from LVOT
measurement
Difficult to measure requires: TR-jet;
PR-jet; good LVOT alignment
Strong independent predictor of mortality
Risk ratio 3.0/mL/mm Hg decrease in PVCAP (95%
confidence interval 1.2–8.0)
Average free RV wall systolic
longitudinal strain141
Cut-off: .212.5% Further standardization required
A 2.9-fold higher rate of death per 5% absolute
decline in RV free wall strain at 1 year
LVOT, left ventricular outflow tract; PR, pulmonary regurgitation; PVCAP, pulmonary vascular capacitance; RA, right atrium; TAPSE, tricuspid annular plane excursion; TR,
tricuspid regurgitation.
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dilatation defines RV myocardial infarction (RVMI).105 Additional
features of RV involvement include paradoxical septal motion
due to increased RV end-diastolic pressure, tricuspid regurgitation,
and severe RA enlargement with possible leftward deviation of the
interatrial septum. Tricuspid annular plane systolic excursion has
been shown to have prognostic value in patients with congestive
heart failure, but its significance in acute RVMI is unclear. Tissue
Doppler studies have demonstrated reduced systolic lateral tricus-
pid velocities in patients with concomitant RVMI and with ischae-
mic RV diastolic dysfunction.106 Recently, the combined used of
lateral tricuspid annulus velocities and RVMPI has been suggested
for detecting RV dysfunction in RVMI in the acute and late
phase.107
Cardiac magnetic resonance is being increasingly used for diag-
nosis and assessment of RV ischaemia. T2-weighted sequences
can depict myocardial oedema and late gadolinium enhancement
suggests fibrosis after RVMI.108 –110 A multicentre prospective
study demonstrated that early postinfarction RV ischaemic injury
is common and is characterized by the presence of myocardial
oedema, late gadolinium enhancement, and functional abnormal-
ities. Right ventricular injury is not limited to inferior infarcts but
also occurs in anterior infarcts. During follow-up, RV dysfunction
may be reversible and permanent myocardial damage limited.59
Late after myocardial infarction, CMR evaluation of RV function
can be used for risk-stratification and refined management of
these patients, as RVEF is an important predictor of prognosis.111
In suspected CAD, MDCT enables accurate visualization of the
coronary arteries, not only of the left but also of the right coronary
artery.79 Compared with invasive coronary angiography, new gen-
eration MDCT offer equal high accuracy but delivers a significantly
lower radiation dose to the patient.80
In patients with congestive heart failure, decreased RV function
has been found to be a critical prognostic factor, in addition to clin-
ical parameters, such as NHYA class and exercise perform-
ance.6,112 Identification of the cause for dilated cardiomyopathy
is crucial for clinical management and guiding treatment. Ischaemic
cardiomyopathy can be accurately ruled out by MDCT, nuclear
techniques, and/or by CMR.79 Different late enhancement
pattern at CMR is indicative for different non-ischaemic causes
of cardiomyopathy, including myocarditis, cardiac amyloidosis, sar-
coidosis, Anderson–Fabry disease, and other storage
diseases.58,113,114
In summary in ischaemic RV disease and RV failure, the different
imaging modalities provide complementary information. Echocardi-
ography is used for basic evaluation and routine follow-up of RV
function, CMR helps distinguish between non-ischaemic and is-
chaemic RV failure and show myocardial oedema and scars after
myocardial infarct, MDCT provides accurate non-invasive imaging
of the coronary arteries.
Arrhythmogenic right ventricular
dysplasia
Arrhythmogenic RV cardiomyopathyopathy is a typical myocardial
disorder affecting primarily the RV. In the early stages of the
disease, structural changes may be subtle or absent and confined
to a localized region of the RV, typically within the so-called
triangle of dysplasia (Figure 8). As ventricular arrhythmia can
occur anytime, affected patients are at risk for sudden death and
timely diagnosis can help preventing arrhythmias and sudden
death.115
The most recent Task Force Criteria (TFC) for diagnosis of
ARVC include global or regional structural and functional altera-
tions, histopathologic tissue characterization, ECG abnormalities,
arrhythmias, and family history.57 Echocardiography and CMR are
the proposed imaging modalities for assessing structural and func-
tional criteria as shown in Table 4. Echocardiographic abnormalities
of the RV can be found in up to 62% of subjects.116 Dilatation of
the RV outflow tract (RVOT) occurs in all positive subjects and
global RV dysfunction is observed in more than two-thirds. Meas-
urement of RVOT dimension in the parasternal long-axis or short-
axis view should be included in each echocardiographic screening
examination, as regional RV enlargement can be missed in the
apical four-chamber view. Additional abnormalities consist of RV
regional wall motion abnormalities, abnormal trabeculations,
hyperreflective moderator band, and sacculations of the RV free
Figure 8 The triangle of dysplasia in arrhythmogenic right ven-
tricular (RV) cardiomyopathyopathy (ARVC). (A) Structural
anomalies can be observed in a region including the subtricuspidal
RV wall, the RV apex, and the RV outflow tract. (B) Steady-state
free precession images showing severe aneurysmatic abnormal-
ities of the RV free wall subtricuspidal (arrows) in a patient
with ARVC.
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wall.116 Tissue Doppler evaluation of myocardial velocities and 3D
echocardiography may be helpful in the early non-invasive diagno-
sis of ARVC.117,118 Cardiac magnetic resonance adds information
to echocardiography, as it enables visualization of subtle changes
and of remote RV segments, such as the RV infero-posterior
wall; RV volumes and function can be quantified (Table 5). Qualita-
tive criteria such as segmental RV dilatation, presence of RV micro-
aneurysms, or fatty infiltration have been removed from the
revised TFC, as they have been shown to have low sensitivity
and specificity.57,119,120 Similar qualitative findings were observed
in patients with benign RVOT arrhythmias in the absence of
ARVC. Fatty infiltration can be found in normal heart as well.115
In summary, each imaging modality should not be used in isola-
tion as an independent marker. The combined use of echocardiog-
raphy and CMR adds a powerful and accurate piece of information
for the diagnosis of ARVC.
Congenital heart disease
In CHD, the RV is frequently exposed to a chronic volume or pres-
sure overload. This is the case in intracardiac shunts (atrial septal
defect), anomalies of the pulmonary valve, and arteries (pulmonary
atresia) and when the RV is pumping in the systemic circulation
(transposition of the great arteries, single ventricle). Eventually,
RV function is the main determinant of prognosis in these patients.
Tetralogy of Fallot is the most common cyanotic CHD and a good
example on how multimodality imaging of the RV can be used in
CHD. Surgical repair of TOF provides excellent survival, but re-
sidual lesions are frequent and determine long-term morbidity
and mortality.121 Echocardiography correctly identifies the presence
of a residual ventricular septal defect, RVOT obstruction, and pul-
monary regurgitation. In TOF patients, 2D echocardiographic mea-
surements of the RV correlate only moderately with RV
end-diastolic volume (RVEDV) as measured by CMR.31,122 The
strongest relationship is found between RV end-diastolic area
from the apical four-chamber view and RVEDV.122 Right ventricular
systolic function can be estimated using % FAC, TAPSE, and tricuspid
annular tissue Doppler velocities. Three-dimensional echocardiog-
raphy is emerging and may be able to replace CMR-based volumet-
ric measurements at least in patients with a good imaging window.34
Diastolic dysfunction in restrictive RV physiology is demonstrated, if
a late diastolic (during atrial contraction) antegrade flow in the pul-
monary artery is shown at Doppler echocardiography.123 Restrictive
RV physiology has been found to have a protective role against pro-
gressive RV dilatation and to better predict exercise performance
late after TOF repair, although this could only be observed in an
adult cohort and is more controversial at younger age.123
Chronic pulmonary valve regurgitation after TOF repair leads to
progressive RV dilatation and dysfunction. Right ventricular volume
measured by CMR has become an important parameter for trying
to determine the ideal timing for pulmonary valve replace-
ment.66,124,125 Oosterhof et al.126 found that a RVEDV
,160 mL/m2 and a RV end-systolic volume ,82 mL/m2 are pre-
dictive for normalization of RV dimensions after pulmonary valve
replacement. In TOF patients, CMR is considered the ideal tool
for serial assessment of RV volumes before and after pulmonary
valve replacement.66
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Table 4 Imaging task force criteria for diagnosing arrhythmogenic right ventricular cardiomyopathyopathy
Structural and functional criteria for ARVC
Major criteria
2D echo Regional RV akinesia, dyskinesia, or aneurysm
And 1 of the following (end-diastole):
RVOT ≥32 mm (19 mm/m2)/parasternal long-axis view
RVOT ≥36 mm (21 mm/m2)/parasternal short-axis view
or RV fractional area change ≤33%
CMR Regional RV akinesia or dyskinesia, or dyssynchronous RV contraction
And 1 of the following:
RV end-diastolic volume ≥110 mL/m2 (male) or ≥100 mL/m2 (female)
or RV ejection fraction ≤40%
Minor criteria
2D echo Regional RV akinesia or dyskinesia
And 1 of the following (end-diastole):
RVOT ≥29 mm ,32 mm (≥16 ,19 mm/m2)
RVOT ≥32 ,36 mm (≥18 ,21 mm/m2)
or fractional area change .33 to ≤40%
CMR Regional RV akinesia or dyskinesia, or dyssynchronous RV contraction
And 1 of the following:
RV end-diastolic volume ≥100 ,100 mL/m2 (male) or ≥90 ,100 mL/m2 (female)
or RV ejection fraction .40 ≤45%
Adapted from: Marcus et al.57 Proposed modification of the Task Force Criteria.
RVOT, RV outflow tract.
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More recently, regional myocardial RV function has been used
for advanced functional assessment after TOF repair. Impaired lon-
gitudinal RV deformation indices have been described in the pres-
ence of pulmonary regurgitation by TDI and speckle tracking.51,127
Interestingly, progressive deterioration of RV longitudinal strain has
been found in patients with stable EF, suggesting that myocardial
strain could be a more sensitive parameter for detecting early ven-
tricular dysfunction.51,128 Acute improvement of longitudinal RV
and septal function could be demonstrated by speckle tracking
after percutaneous pulmonary valve replacement.129
Velocity-encoded CMR imaging of RV myocardium provides
similar myocardial velocities and timing of velocities as TDI. Peak
systolic velocities in the RV free wall and in the RVOT are
reduced in TOF patients compared with normals.130
The importance of the infundibulum has been investigated by
looking at the segmental function in different RV regions, distin-
guishing between the RV inlet, the trabeculated apical part, and
the RV outlet. Not surprisingly, EF is predominantly reduced in
the outlet part where the surgical patch has been inserted.131
This reduced myocardial deformation in the infundibular region
correlates well with areas of late enhancement as well as with
global EF.132
Cardiac magnetic resonance provides important additional infor-
mation, including calculation of pulmonary regurgitant volume and
fraction,73 measurement of differential lung perfusion,133 and
late-enhancement imaging.61 The presence of RV myocardial
scars has been reported to have prognostic relevance in TOF
patients, as it correlates with RV size, function, length of QRS
complex at ECG, and may predict ventricular arrhythmias.134
Contrast-enhanced MR angiography or 3D SFFP provides exact
anatomical evaluation of the RVOT and the pulmonary arteries
and is helpful for planning reinterventions55 particularly for select-
ing patients for percutaneous pulmonary valve replacement.135
Conclusions
The significance of RV function is being increasingly recognized in
the acute phase and during follow-up as prognostic factor in
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 5 Summary of the right ventricular parameters that can be assessed by specific and/or combined imaging
modalities in various diseases
Measurements Imaging modality Disease
RV anatomy Echocardiography All
CMR (SSFP) CHD
MDCT
RV dimensions 2D echocardiography All
CMR (SSFP, volumetry) CHD
MDCT ARVC (RVOT)
Pulmonary valve Echocardiography CHD
CMR (phase contrast imaging for regurgitation quantification)
Pulmonary arteries CMR (angiography/3D SSFP) CHD
MDCT PAH, pulmonary embolism
Echocardiography (proximal segments)
Tricuspid valve Echocardiography All
3D echocardiography
RV volumes CMR (SSFP) All
RV ejection fraction Echocardiography (2D/3D)
Gated blood-pool SPECT
MDCT
Regional RV function Tissue Doppler imaging All
Myocardial velocities Speckle tracking
Strain/strain rate (investigational) CMR (tagging, velocity encoded sequences)
RV ischaemia CMR (late enhancement, oedema) RV ischaemic disease
Echocardiography (wall motion) RV failure
SPECT (perfusion)
RV scars/fibrosis CMR (late enhancement) RV failure
SPECT RV ischaemic disease
Myocarditis
CHD
Coronary arteries MDCT RV ischaemic disease
PET/CT
The imaging modalities are represented in the order they should be performed for the specific wanted measurement.
ARVC, arrhythmogenic right ventricular cardiomyopathy; CHD, congenital heart disease; CMR, cardiovascular magnetic resonance; MDCT, multidetector computed tomography;
RVOT, right ventricular outflow tract; PAH, pulmonary arterial hypertension; PET, positron emission tomography; SPECT, single-photon electron-computed tomography; SSFP,
steady-state free precession sequence.
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several cardiac diseases. Echocardiography and CMR are the
imaging modalities of choice for imaging the right heart. In most
patients, both techniques provide complementary information
and can be used in combination for almost complete evaluation
of the RV. Multidetector computed tomography and nuclear
imaging technique are valuable alternative modalities and add im-
portant additional information in selected cases, particularly in
RV ischaemic disease. Emerging new technologies such as 3D
echocardiography, TDI, speckle tracking as well as new CMR se-
quence are enlarging the spectrum of the pathophysiologic infor-
mation obtained, but are still confined to investigational use and
need further clinical validation. Table 5 summarizes the use of all
these imaging modalities for assessing the different RV parameters
in various diseases, and may serve as guide for multimodality
imaging.
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